How many patents does
Sanford-Burnham Medical Research Institute have?
patents
708
families
138
granted
162
applications
546
US
302
WO
132
EP
97
JP
43
CN
18
KR
9
RoW
107
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Sanford-Burnham Medical Research Institute
Top ten assignees appearing on patents
2009 - 2018
| vascular biosciences | 9 |
| illumina | 8 |
| pfizer | 6 |
| calasia pharmaceuticals | 5 |
| burnham inst for medical research | 4 |
| biotime | 3 |
| mandala biosciences | 2 |
| chemregen | 2 |
| braincells | 2 |
| vala sciences | 2 |
2009
| illumina | 2 |
2018
| pfizer | 5 |
| vala sciences | 2 |
| vascular biosciences | 1 |
Sanford-Burnham Medical Research Institute
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| sulfonamide compounds and uses as tnap inhibitors | 19 | 2012 |
| methods and compositions related to a retinoid receptor-selective pathway | 19 | 2010 |
| quinazolinone analogs and use of quinazolinone analogs for treating or preventing certai… 🛈 | 19 | 2011 |
| methods and compositions related to internalizing rgd peptides | 18 | 2008 |
| naphthalene-based inhibitors of anti-apoptotic proteins | 16 | 2009 |
| apogossypolone derivatives as anticancer agents | 16 | 2009 |
| hiv replication inhibitors | 16 | 2011 |
| methods and compounds useful to induce apoptosis in cancer cells | 15 | 2003 |
| methods and compositions related to targeting tumors and wounds | 13 | 2006 |
| btla fusion protein agonists and uses thereof | 13 | 2015 |